Overview
Michel Hoessly is a Hematologist Oncology specialist and a Hematologist in Wilkes Barre, Pennsylvania. Dr. Hoessly and is rated as an Advanced provider by MediFind in the treatment of PEPCK 1 Deficiency. His top areas of expertise are Thrombocytopenia, Autoimmune Hemolytic Anemia, Schnitzler Syndrome, and Monoclonal Gammopathy of Undetermined Significance (MGUS).
Insurance
Please contact the provider to confirm they accept your insurance or if you don't see your insurance listed.
Accepted insurance plans
- Humana
Locations
1000 E Mountain Dr, Wilkes Barre, PA 18711
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
MediFind cannot find any recent clinical research or clinical trials for Dr. Michel C. Hoessly
Areas of Expertise
When evaluating expertise, MediFind pulls from factors such as the number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
To learn more about how MediFind determines the expertise levels, check out our expert tiers page.
- Distinguished
- Autoimmune Hemolytic Anemia
- Familial Colorectal Cancer
- Familial Pancreatic Cancer
- Iron Deficiency Anemia
- Lung Cancer
- Monoclonal Gammopathy of Undetermined Significance (MGUS)
- Advanced
- Adult Immune Thrombocytopenia
- Autosomal Recessive Congenital Methemoglobinemia
- Childhood Iron Deficiency Anemia
- Cholangiocarcinoma (Bile Duct Cancer)
- Chronic B-Cell Leukemia (CBCL)
- Chronic Lymphocytic Leukemia (CLL)
- Experienced
- Acute Monoblastic Leukemia (AmoL)
- Acute Mountain Sickness
- Acute Myeloblastic Leukemia with Maturation
- Acute Myeloblastic Leukemia without Maturation
- Acute Myeloid Leukemia (AML)
- Acute Myelomonocytic Leukemia